Rosetta Genomics Ltd
OTC:ROSGQ
Rosetta Genomics Ltd
Current Portion of Long-Term Debt
Rosetta Genomics Ltd
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Rosetta Genomics Ltd
OTC:ROSGQ
|
Current Portion of Long-Term Debt
$55k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Current Portion of Long-Term Debt
$1.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-16%
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Current Portion of Long-Term Debt
₪1.5m
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Rosetta Genomics Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
55k
USD
Based on the financial report for Dec 31, 2016, Rosetta Genomics Ltd's Current Portion of Long-Term Debt amounts to 55k USD.
What is Rosetta Genomics Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
13%